Identifying & optimizing of the gene of the target protein. which is followed by synthesizing the selected DNA**
**supervised by a certified CRO
Our Technology
The upstream process performed mainly in open field agricultural settings, making the platform’s scalability and the ability to respond to market needs limited only by the number of hectares available and by the 3-month growth cycle.
Our proprietary purification process is based on a chimeric protein produced in planta, which results in substantial cost reductions and enormous scalability in the downstream process, which makes BioBetter the cutting-edge solution for today’s industrial needs.
Applications requiring clean rooms (such as in the production of therapeutic proteins) are limited to a tiny footprint compared to alternative production systems.
Our Process
Identifying & optimizing of the gene of the target protein. which is followed by synthesizing the selected DNA**
**supervised by a certified CRO
Cloning the gene into BioBetter expression vectors, which have been optimized for specific functionalities and higher yields
Transferring the gene into tobacco plants
Selecting the top protein-expressing plants, which are breed further to arrive at the highest yielding, industrial-scale plant line for producing the target protein
Growing the selected tobacco plant lines (in nethouses), utilizing traditional agricultural methods
Harvesting when the plants are ready
After a few simple steps in a non-classified facility, extracting and purifying the target protein (to affinity chromatography purity grade), without using chromatography equipment
Our technology will drive substantial changes in the foodtech and healthcare industries,
by delivering better, more accessible products, without compromising on quality, efficiency, and efficacy.